Emergent BioSolutions (United Kingdom)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
63
Total Open
Publications
45
Total
Citations
815
Open Access
Percentage
71%
Total
Publications
63
Total Open
Publications
45
Total
Citations
815
Breakdown
Publisher Open
40%
Both
25%
Other Platform Open
5%
Closed
30%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 56%
22
Hybrid 26%
10
No Guarantees 18%
7
Other Platform Open
Institution 50%
10
Domain 45%
9
Public 20%
4
Other Internet 15%
3
Preprint 5%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 9 |
DOI | Other Internet | 3 |
University of Melbourne | Institution | 2 |
Open Research Library | Public | 2 |
Figshare | Public | 2 |
University of Oxford | Institution | 1 |
University of Minnesota Rochester | Institution | 1 |
University of KwaZulu-Natal | Institution | 1 |
Universitat Jaume I | Institution | 1 |
Universitat Autònoma de Barcelona | Institution | 1 |